Insider Cluster (2 insiders) ·Filed Jun 2, 2026

VIR

Vir Biotechnology, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $34K total
Actionable Insight • Neutral

Insider sales are negligible in size and follow routine director grants — no bearish signal. Monitor upcoming quarterly results for pipeline updates, as Vir's valuation is driven by clinical catalysts, not insider trading patterns.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
VIR ▲ +28.96% at T+60d
NEUTRAL call ✓ call won +28.96% · α vs SPY +26.46% · entry $8.77 → $11.31
Entry anchored
Jun 2, 2026
via day open
T+1d
+4.33%
call +4.33% · α +3.93%
$9.15
settled 4mo ago
T+5d
-5.93%
call -5.93% · α -2.11%
$8.25
settled 4mo ago
T+20d
+14.48%
call +14.48% · α +15.48%
$10.04
settled 3mo ago
T+60d
+28.96%
call +28.96% · α +26.46%
$11.31
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Vir Biotechnology sold a combined $34K in open-market sales on June 1, 2026, following a wave of non-cash director stock grants on May 27. The dollar amount is trivial relative to the $1.5B market cap (0.002%), and the sales are likely liquidity-driven rather than signaling bearish conviction. The cluster is not informative.

Key Financial Metrics

Direction
selling
Total Value
$33.8K
Insiders
2

Key Facts

  • Director Janet Napolitano sold 3,200 shares at $9.45 for $30,240 on June 1, 2026.
  • SVP/CAO Brent Sabatini sold 379 shares at $9.45 for $3,582 on June 1, 2026.
  • Total open-market sales: $33,822, representing ~0.002% of Vir's $1.5B market cap.
  • On May 27, 2026, six directors received non-cash stock grants totaling 128,000 shares (value $0).
  • Prior 30-day insider activity: only $34K in sales, consistent with routine patterns.

Financial Impact

Total insider sales of $34K are immaterial against $1.5B market cap.

insider holdings

Risk Factors

  • Insider sales, though small, could precede negative clinical data if insiders have material non-public information — but the dollar amount is too low to suggest this.
  • Historical calibration shows cluster reports on VIR have a 40% win rate at T+20, suggesting limited predictive power for this ticker.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-VIR-1780436144771
18 reports for VIR
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$9.24 $9.78▲ +5.84%▲ +7.21%$11.16 (+20.78%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$8.89 $9.39▲ +5.62%▲ +5.67%$11.16 (+25.53%)
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$8.69 $8.90▲ +2.42%▲ +2.04%$11.16 (+28.42%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$10.38 $10.02▼ −3.47%▼ −4.86%$11.16 (+7.51%)
Jun 10, 2026
16w ago
3
NEUTRAL ★ 1/10
$8.52 $9.30▲ +9.15%▲ +8.72%$11.16 (+30.99%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$8.52 $9.30▲ +9.15%▲ +8.72%$11.16 (+30.99%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $8.25▼ −5.93%▼ −2.11%$11.16 (+27.25%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$9.55 $8.77▼ −8.17%▼ −8.12%$11.16 (+16.86%)
Apr 16, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.35▲ +0.19%▼ −0.79%$11.16 (+8.03%)
Apr 10, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$9.31 $11.09▲ +19.12%▲ +15.82%$11.16 (+19.87%)
Showing 10 of 18

US Market Status

Market Open — Closes in 2h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 2, 2026